SCHEMBL4384036

SCHEMBL4384036

O=C(O)C1(C(=O)Cc2ccccc2)CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.47
CES2 O00748 1/20 0.47
AKR1B1 P15121 1/20 0.47
AKR1C1 Q04828 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 3/20 0.42
ADRB2 P07550 1/20 0.42
HTT P42858 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
EPHX2 P34913 2/20 0.41
FAAH O00519 1/20 0.41
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8391674 0.78 CES1 (0.47) CES1CES2AKR1B1AKR1C1NPC1
SCHEMBL10608700 0.78 CES1 (0.47) CES1CES2AKR1B1ALDH1A1ADRB2
SCHEMBL8393399 0.76 CES1 (0.45) CES1CES2AKR1B1AKR1C1NPC1
SCHEMBL8394743 0.76 CES1 (0.45) CES1CES2AKR1B1AKR1C1NPC1
SCHEMBL12503374 0.76 CTBP2 (0.46) NPC1RAB9AALDH1A1HTTKMT2A
SCHEMBL8396802 0.75 CES1 (0.44) CES1CES2AKR1B1AKR1C1NPC1
SCHEMBL8394052 0.74 CES1 (0.47) CES1CES2AKR1B1NPC1RAB9A
SCHEMBL595870 0.74 DDB1 (0.51) ALDH1A1KMT2AMAPK1L3MBTL1
SCHEMBL7435493 0.74 MMP8 (0.57) ALDH1A1MEN1KMT2AHPGDL3MBTL1
SCHEMBL8393666 0.74 ALDH1A1 (0.43) CES1CES2AKR1B1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629340-B2 N-(6-membered aromatic ring)-amido anti-viral compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-12-08 US disclosed
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS ZC3HAV1, HAVCR2, ZC3HAV1L CES1 2113/4885CES2 2966/4885AKR1B1 2250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.